Fluifort granules 2.7g / 5g pack. 10 pieces

Description

Composition
Active substance:
carbocisteine ​​lysine salt monohydrate 2.7 g
Excipients:
Citric Acid 0.080 g, 0.9185 g of mannitol, povidone 0.1 g flavoring 0.04 g cedar natural, natural orange flavor 0.04 g, orange juice powder 0.2960 g, aspartame 0.03 g, maltodextrin 0 7955 g
Description:
The granules from white to light yellow in color.
The reconstituted solution matte light yellow color with a citrus odor.
Product form:
10 bags of 2.7 g / 5 g in a cardboard package with instructions for use.
Contraindications
Hypersensitivity to Karbotsistein, duodenal ulcer and gastric (exacerbation). Children under 16 years, pregnancy (I trimester), lactation, phenylketonuria.
Carefully
Pregnancy (II-III trimester), gastric ulcer and duodenal ulcer (in history).
Dosage
2.7 g / 5 g
Indications
Acute and chronic bronchopulmonary disease, accompanied by the formation of a viscous and sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis) and mucus (inflammatory disease of middle ear and sinuses – rhinitis,
adenoids, otitis media, sinusitis), preparation of the patient for bronchoscopy or bronhografii.
Interaction with other drugs
Currently no known cases of interaction and carbocisteine ​​drugs commonly used in the treatment of respiratory diseases. There were no interaction between the drug and food products, as well as substances used for laboratory studies. The effect is attenuated antitussive drugs and M-anticholinergic drugs. Enhances effectiveness of glucocorticoids (mutually) and antibiotic therapy of infectious and inflammatory diseases of the upper and lower respiratory tract.
Enhances the bronchodilator effect of theophylline.
Overdose
Currently, the cases of drug overdose Fluifort were reported.
Possible overdose symptoms include stomach pain, nausea, diarrhea.
Treatment: cimptomaticheskoe. Specific antitoda does not exist.
pharmachologic effect
Pharmacological group:
mucolytic agent.
Pharmacological properties:
Mucolytic and expectorant action is caused by activation of sialic transferase – enzyme goblet cells of the bronchial mucosa.
Normalizes the proportion of acidic and neutral sialomutsinov bronchial secretions, recovers viscosity and elasticity of the mucus.
Promotes regeneration of the mucosa, it normalizes its structure,
activates the activity of ciliated epithelium. Restores the secretion of immunologically active IgA (specific protection) and the number of sulfhydryl groups mucus components (non-specific protection), improves mucociliary clearance.
Pharmacokinetics:
It is rapidly and completely absorbed following oral administration. Maximum concentration in the blood and secretion is achieved within the first hour after ingestion. Therapeutic blood concentration is maintained for 8 hours.
T1 / 2 -1.8 hours (at a dose of 2 g / day).
Excreted mainly in urine, approximately 30-60% – unchanged, the rest – in the form of metabolites.
Pregnancy and breast-feeding
It is not recommended to use the drug in 1 trimester of pregnancy and during breastfeeding.
Conditions of supply of pharmacies
Without recipe.
side effects
For karbotsisteina characterized by the following side effects – rare: gastritis,
nausea, diarrhea, dizziness, malaise, skin rashes.
Lysine salt karbotsisteina – rare: epigastric pain, nausea, diarrhea; skin rash.
All of these disorders are transient and disappear after discontinuation of the drug or after dosage reduction.
If you notice any – any side effects, contact your doctor.
special instructions
C first days of taking the drug, due to improved secretion output amplified expectorant effect.
Fluifort in the form of a granular composition for oral administration contains podstlastitel aspartame. This substance is contraindicated to patients suffering from phenylketonuria.
Application Fluiforta does not lead to occurrence of metabolic dependence or addiction.
Treatment can be combined with physiotherapy.
Storage conditions
At temperatures above 25 ° C.
Keep out of the reach of children!
Dosing and Administration
Inside.
Adults: 1 sachet per day.
Dissolve the contents of the sachet in the drinking water, stir.
The duration of treatment is determined by the doctor (from 4 days to 6 months).
Said dosage is stored for patients with impaired liver function and kidney disease, and patients suffering from diabetes.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist